AKAGERA Medicines
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
271 Waverly Oaks Rd, Waltham, Massachuse...Website
www.akageramedicines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About AKAGERA Medicines
AKAGERA Medicines is a Rwandan biotech company focused on developing novel liposomal formulations of antibacterial drugs to treat tuberculosis and other infectious diseases. Founded in 2018, the company aims to address the rising drug-resistant forms of TB, particularly among vulnerable populations. Their product pipeline includes therapeutics for MRSA and vaccine candidates for various infectious diseases, developed in collaboration with prominent organizations like the Gates Foundation and NIH. With laboratories in Boston and San Francisco, AKAGERA Medicines is committed to innovative solutions for global health challenges.Explore more
AKAGERA Medicines Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AKAGERA Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AKAGERA Medicines had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at AKAGERA Medicines
AKAGERA Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if AKAGERA Medicines is spiking on competitors!
Funding: Get notified immidiatlly once AKAGERA Medicines has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on AKAGERA Medicines recently announced quarterly report
Product Launch: Get notified when AKAGERA Medicines launches new products
Check if AKAGERA Medicines has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to AKAGERA Medicines
Compare insights from companies similar to AKAGERA Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AKAGERA Medicines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AKAGERA Medicines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AKAGERA Medicines.
AKAGERA Medicines Tech Stack
A closer look at the technologies used by AKAGERA Medicines
AKAGERA Medicines News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AKAGERA Medicines
Sign Up For FreeTo access detailed company insights
AKAGERA Medicines is a Rwandan biotech company focused on developing novel liposomal formulations of antibacterial drugs to treat tuberculosis and other infectious diseases. Founded in 2018, the company aims to address the rising drug-resistant forms of TB, particularly among vulnerable populations. Their product pipeline includes therapeutics for... Read More
